313 related articles for article (PubMed ID: 18752389)
1. Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
Tuteja S; Pyrsopoulos NT; Wolowich WR; Khanmoradi K; Levi DM; Selvaggi G; Weisbaum G; Tzakis AG; Schiff ER
Pharmacotherapy; 2008 Sep; 28(9):1188-93. PubMed ID: 18752389
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe/simvastatin.
Montecucco F; Quercioli A; Mach F
Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM
Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742
[TBL] [Abstract][Full Text] [Related]
4. ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced autoimmunity?
Sen D; Rosenstein ED; Kramer N
Int J Rheum Dis; 2010 Aug; 13(3):e29-31. PubMed ID: 20704607
[TBL] [Abstract][Full Text] [Related]
5. Striated muscle safety of ezetimibe/simvastatin (Vytorin).
Davidson MH; Maccubbin D; Stepanavage M; Strony J; Musliner T
Am J Cardiol; 2006 Jan; 97(2):223-8. PubMed ID: 16442367
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
7. Tendon rupture associated with simvastatin/ezetimibe therapy.
Pullatt RC; Gadarla MR; Karas RH; Alsheikh-Ali AA; Thompson PD
Am J Cardiol; 2007 Jul; 100(1):152-3. PubMed ID: 17599460
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
9. Myopathy associated with atorvastatin-ezetimibe combination therapy.
Weffald LA; Flach LA
Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
[TBL] [Abstract][Full Text] [Related]
10. Safety considerations with gastrointestinally active lipid-lowering drugs.
Jacobson TA; Armani A; McKenney JM; Guyton JR
Am J Cardiol; 2007 Mar; 99(6A):47C-55C. PubMed ID: 17368279
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
13. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
14. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
15. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
[TBL] [Abstract][Full Text] [Related]
16. Severe jaundice following treatment with ezetimibe.
Ritchie SR; Orr DW; Black PN
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):572-3. PubMed ID: 18467918
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe-associated immune thrombocytopenia.
Pattis P; Wiedermann CJ
Ann Pharmacother; 2008 Mar; 42(3):430-3. PubMed ID: 18252832
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
19. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
Aalbers J
Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
[No Abstract] [Full Text] [Related]
20. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis.
Johnson JL; Loomis IB
Pharmacotherapy; 2006 Mar; 26(3):414-22. PubMed ID: 16503723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
